Nanoparticles Drug Delivery System in Targeted Therapy of Hepatocellular Carcinoma

This article presents a comprehensive overview of the application of nanoparticles drug delivery system in the detection and treatment of Hepatocellular Carcinoma (HCC). The nanoparticles drug delivery system, endowed with exceptional physical and chemical features, including remarkable drug-carrying capacity, precise targeting abilities, and visualization capabilities, offer promising new avenues for addressing HCC. Nanomaterials are important components of nano-drug delivery systems. Their utilization in HCC therapy, along with the advantages and disadvantages of various nanomaterials, including lipid, polymer, inorganic, biological macromolecular nanomaterials, exosomes and also hybrid nanoparticles, are thoroughly discussed. Our review identifies lipid nanoparticles as widely utilized bioactive nanocarriers in cancer treatment, with polylactic acid, a pioneering biodegradable polyester polymer, showing significant application potential. Additionally, hybrid nanoparticles, which combine the advantages of individual nanoparticles while mitigating their drawbacks, are poised to play a critical role in the targeted therapy of HCC. Additionally, the article delves into the targeting and release mechanisms of nanoparticles drug delivery system, encompassing passive targeting, active targeting, stimulus-responsive nanocarrier targeting, and specific types of it like pH stimulus-responsive nanocarriers. Despite their immense potential in HCC treatment, nanoparticles drug delivery system still faces numerous challenges, such as safety concerns, drug stability issues, and inadequate fundamental research for widespread application. As these challenges are gradually overcome, nanotechnology will open up new horizons for HCC diagnosis and treatment, leading to the development of more precise diagnostic tools and therapeutic strategies. Overall, the research on targeted nanoparticles drug delivery system therapy for HCC is entering an exciting new era filled with both opportunities and challenges.

Authors

Publication Details

Journal
Diseases & Research
Published
2024-10-24
DOI
https://doi.org/10.54457/dr.202402007
Citations
1
Primary Topic
Curcumin's Biomedical Applications
Type
article
Field-Weighted Citation Impact
0.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanoparticles Drug Delivery System in Targeted Therapy of Hepatocellular Carcinoma

Hongyu Tang, Yihang Chen, Juan Li, Zirui Zhang et al.
1 citations
Diseases & Research
Curcumin's Biomedical Applications
0.17
article

Nanoparticles Drug Delivery System in Targeted Therapy of Hepatocellular Carcinoma

Hongyu Tang, Yihang Chen, Juan Li, Zirui Zhang, Xinyuan Kong
article en
1 citations

Abstract

This article presents a comprehensive overview of the application of nanoparticles drug delivery system in the detection and treatment of Hepatocellular Carcinoma (HCC). The nanoparticles drug delivery system, endowed with exceptional physical and chemical features, including remarkable drug-carrying capacity, precise targeting abilities, and visualization capabilities, offer promising new avenues for addressing HCC. Nanomaterials are important components of nano-drug delivery systems. Their utilization in HCC therapy, along with the advantages and disadvantages of various nanomaterials, including lipid, polymer, inorganic, biological macromolecular nanomaterials, exosomes and also hybrid nanoparticles, are thoroughly discussed. Our review identifies lipid nanoparticles as widely utilized bioactive nanocarriers in cancer treatment, with polylactic acid, a pioneering biodegradable polyester polymer, showing significant application potential. Additionally, hybrid nanoparticles, which combine the advantages of individual nanoparticles while mitigating their drawbacks, are poised to play a critical role in the targeted therapy of HCC. Additionally, the article delves into the targeting and release mechanisms of nanoparticles drug delivery system, encompassing passive targeting, active targeting, stimulus-responsive nanocarrier targeting, and specific types of it like pH stimulus-responsive nanocarriers. Despite their immense potential in HCC treatment, nanoparticles drug delivery system still faces numerous challenges, such as safety concerns, drug stability issues, and inadequate fundamental research for widespread application. As these challenges are gradually overcome, nanotechnology will open up new horizons for HCC diagnosis and treatment, leading to the development of more precise diagnostic tools and therapeutic strategies. Overall, the research on targeted nanoparticles drug delivery system therapy for HCC is entering an exciting new era filled with both opportunities and challenges.

Diseases & ResearchVol. 5(1)
Good health and well-being
Openalex Percentile: Top 56%
Curcumin's Biomedical Applications
0.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.